MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 74 filers reported holding MEREO BIOPHARMA GROUP PLC in Q2 2021. The put-call ratio across all filers is 0.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $10,754,000 | -46.8% | 3,392,136 | -43.5% | 0.07% | -72.7% |
Q1 2021 | $20,220,000 | +10712.8% | 6,000,000 | +3244.1% | 0.26% | +5020.0% |
Q1 2020 | $187,000 | -68.2% | 179,419 | 0.0% | 0.01% | -58.3% |
Q4 2019 | $588,000 | +10.1% | 179,419 | 0.0% | 0.01% | -14.3% |
Q3 2019 | $534,000 | +18.1% | 179,419 | 0.0% | 0.01% | +40.0% |
Q2 2019 | $452,000 | – | 179,419 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
COMMODORE CAPITAL LP | 1,854,278 | $6,638,000 | 3.61% |
Asymmetry Capital Management, L.P. | 739,812 | $2,649,000 | 1.21% |
Affinity Asset Advisors, LLC | 625,000 | $2,238,000 | 1.19% |
Tri Locum Partners LP | 728,710 | $2,609,000 | 0.95% |
Boxer Capital, LLC | 6,226,673 | $22,291,000 | 0.72% |
DAFNA Capital Management LLC | 668,148 | $2,392,000 | 0.71% |
Vivo Capital, LLC | 4,220,938 | $15,111,000 | 0.67% |
Delphi Management Partners VIII, L.L.C. | 256,734 | $919,000 | 0.60% |
SILVERARC CAPITAL MANAGEMENT, LLC | 280,000 | $1,002,000 | 0.58% |
Rubric Capital Management LP | 1,853,417 | $6,635,000 | 0.49% |